UK Borrowing Reaches Highest Level Since Pandemic as Retail Sales Dip Amid Fuel Price Surge Professional Title Copper Tariff Speculation Resurfaces Disrupting Global Metal Flows Taiwan Chip Stocks Rise Amid Nvidias 150 Billion Spending Announcement Gap and American Eagle Fall as Apparel Demand Concerns Weigh on Investor Sentiment Burberry Shares Surge on Report of Potential Moncler Takeover Bid Bitcoin Price Pattern Echoes 2022 Downturn With Intensified Decline ARQ Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Higher CXApp Inc CXAI Q1 2026 Earnings EPS Surprises Positively Amid Revenue Uncertainty Timken Q1 2026 Earnings EPS Surprises to the Upside as Operational Discipline Drives Results Roper Technologies Q1 2026 Earnings EPS Beats Estimates as Margins Drive Performance BATRA Q1 2026 Earnings NarrowerThanExpected Loss as Braves Navigate Seasonality Willis Lease Finance Corporation WLFC Q1 2026 Earnings Strong EPS Beat Driven by Asset Utilization and Leasing Demand Monte Rosa Therapeutics GLUE Edges Lower Holding Near Key Support Level Telekomunikasi Indonesia TLK Declines 47 Testing Key Support as Telecom Sector Faces Pressure Horizon Quantum Holdings HQ Surges 543 Key Levels to Watch After Breakout Elanco Animal Health ELAN Gains 192 as Shares Approach Key Resistance WhiteHorse Finance Notes WHFCL Hold Steady at 2555 Amid Narrow Trading Range Arcellx ACLX Q4 2025 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage COSM Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines Slightly Post Holdings Inc POST Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency MTNB Q4 2024 Earnings Narrowing Losses Surprise as Biotech Advances Pipeline Without Revenue IDR Q1 2026 Earnings EPS Misses Estimates as Stock Slips 29 Autoliv Q1 2026 Earnings EPS Beats Estimates by 66 Stock Rises 2 Solaris Energy Infrastructure SEI Completes Nearly 2 Billion in Financing and Expands Contract Portfolio RCAT Q1 2026 Earnings Negative EPS Surprise as Strategic Initiatives Continue Alzamend Neuro ALZN Slides 174 as Stock Tests Key Support at 107